Status:
COMPLETED
Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is conducted in Europe. The aim of this observational study is to observe the efficacy of Levemir® treatment in patients with type 2 diabetes in everyday clinical practice in Switzerland. F...
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes mellitus
- Insulin-naive or currently treated with another basal insulin
- Inclusion of patients at the discretion of the treating physician after the decision to prescribe Levemir®
Exclusion
- Type 1 diabetes mellitus
- Patients treated with short acting or with premix insulin
- Women who are pregnant, breast feeding or have the intention to become pregnant
- Known or suspected allergy to the study product or related product
- Any exclusion criteria according to the Swiss Levemir® SPC (Summary of Product Characteristics)
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
1074 Patients enrolled
Trial Details
Trial ID
NCT00793273
Start Date
November 1 2008
End Date
January 1 2011
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zurich, Oerlikon, Switzerland, CH-8050